Enzymatic Therapy, Inc. Wins Families in Good Company Award

Green Bay, WI, October 23, 2008 --(PR.com)-- These days it can be tough to find a balance between life and work issues, but nutritional supplement leader, Enzymatic Therapy, has developed multiple ways to help its associates. The company’s family-friendly efforts have won the Families in Good Company award, presented by the Green Bay Area Chamber of Commerce.

Families in Good Company recognizes Greater Green Bay Area employers who have family-friendly policies that take that “extra-step” to assist balancing the responsibilities of work and family life.

Enzymatic Therapy efforts include flexible schedules and telecommuting, health-related workshops, mentoring programs and educational assistance.

The company also encourages employees to become involved in humanitarian, community sponsored activities and covers registration fees.

“We’re proud to be recognized as a family-friendly business,” said Tina Fairbairn, Enzymatic Therapy Benefits Specialist. “Our efforts to assist associates find a healthy life-work balance reflect our company’s first core value – a sincere respect for people.”

Enzymatic Therapy works very hard to make sure employees feel respected, useful, and proud of the company they work for and the products that they stand behind. Along with excellent employees benefit packages and health incentive programs, the company also has an onsite gym, exercise and wellness classes, chiropractic care and massage therapy.

For more than 30 years, Enzymatic Therapy, Inc., (ETI) based in Green Bay, Wisconsin, has been North America’s leading manufacturer and distributor of dietary supplements and natural medicines. ETI is an FDA-registered drug establishment and also a certified organic processor. It was the first company to introduce Ginkgo biloba, glucosamine sulfate and botanical standardization to the United States health market. The company’s products and ingredients are collectively the subject of over 2,500 independent, peer-reviewed-published clinical trials and studies. For more information visit enzy.com.

###